PT - JOURNAL ARTICLE AU - Butt, Maliha AU - Nagpal, Shavy AU - Phillips, Ellex AU - Shah, Shazia Q. AU - Dogar, Zeryab AU - Loh, Hanyou AU - Mishra, Sakshi AU - Vijayan, Rupalakshmi AU - Jeyakumar, Rishan AU - Makkar, Sarabjot Singh AU - Jahan, Samia AU - Díaz, Gabriela Marie AU - Franca, Hudson AU - Javed, Schaza AU - Belizaire, Marie-Pierre AU - Somagutta, Manoj Reddy TI - Navigating the Neurological Aftermath of COVID-19: An In-Depth Exploration AID - 10.1101/2023.09.10.23295343 DP - 2023 Jan 01 TA - medRxiv PG - 2023.09.10.23295343 4099 - http://medrxiv.org/content/early/2023/09/12/2023.09.10.23295343.short 4100 - http://medrxiv.org/content/early/2023/09/12/2023.09.10.23295343.full AB - Background The COVID-19 pandemic caused by SARS-CoV-2 has affected millions of people and can result in both immediate and prolonged neurological effects, including severe complications. While numerous studies have explored the occurrence and consequences of neurological issues in COVID-19, they have often involved limited sample sizes.Purpose This paper aims to determine the overall occurrence of neurological complications in COVID-19, examine their links with patient demographics, and assess their impact on patient outcomes. Additionally, it seeks to provide an overview of the current understanding of the underlying mechanisms.Methodology Two systematic reviews were conducted to investigate acute and chronic neurological complications associated with COVID-19. A comprehensive search of medical databases was performed, and relevant studies were evaluated following PRISMA guidelines. Meta-analysis was carried out using the Mantel-Haenszel method, with subgroup analysis and meta-regression used to assess heterogeneity.Results The analysis of acute complications included 20,011 patients with an average age of 58.1 years and a slight male predominance (55.2%). Common neurological symptoms included loss of taste and smell, headaches, acute encephalopathy, and stroke. For the analysis of long-term complications, 2,094 patients were included. Survivors of COVID-19 experienced ongoing neurological issues ranging from sensory impairments to fatigue, headaches, strokes, and even cognitive and psychiatric problems.Conclusion By examining various neurological symptoms, this study found a significant association between these manifestations and worse overall outcomes, especially in patients over 60 years old. Identifying high-risk individuals and maintaining a high level of suspicion are crucial for enhancing our understanding of the underlying mechanisms, validating biomarkers, and improving the management of these neurological issues.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript